ACAD
37.04
+0.3
+0.82%
AEMD
6.23
-0.06
-0.95%
APRI
0.309
-0.012
-3.8641%
ARNA
1.67
-0.01
-0.60%
ATEC
0.41
+0.03
+7.92%
CNAT
2.26
-0.03
-1.31%
CRXM
0.177
-0.003
-1.667%
CYTX
2.17
+0.12
+5.85%
DXCM
92.23
+2.67
+2.98%
GNMK
10.65
+0.39
+3.80%
HALO
9.94
+0.17
+1.74%
ILMN
166.35
-0.07
-0.04%
INNV
0.54
-0.01
-1.80%
INO
9.88
+0.26
+2.70%
ISCO
1.99
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
134.88
-0.01
-0.01%
LPTN
1.95
-0.05
-2.50%
MBVX
0.6
-0.05
-7.69%
MEIP
1.36
0.00
-0.01%
MNOV
6.2
+0.13
+2.14%
MRTX
4.64
+0.08
+1.75%
MSTX
0.357
-0.006
-1.6249%
NBIX
50.23
+0.08
+0.16%
NUVA
62.2
+0.18
+0.29%
ONCS
1.82
+0.03
+1.68%
ONVO
4.28
-0.01
-0.23%
OREX
3.35
-0.03
-0.89%
OTIC
14.36
-0.1
-0.69%
QDEL
22.8
-0.44
-1.89%
RCPT
231.96
0.00
0.00%
RGLS
3.57
0.00
+0.14%
RMD
68.88
+3.18
+4.84%
SPHS
5.86
+0.46
+8.52%
SRNE
6.29
+0.1
+1.62%
TROV
5.63
+0.18
+3.30%
VICL
4.15
-0.05
-1.19%
VOLC
18
0.00
0.00%
ZGNX
9.13
+0.05
+0.55%
ACAD
37.04
+0.3
+0.82%
AEMD
6.23
-0.06
-0.95%
APRI
0.309
-0.012
-3.8641%
ARNA
1.67
-0.01
-0.60%
ATEC
0.41
+0.03
+7.92%
CNAT
2.26
-0.03
-1.31%
CRXM
0.177
-0.003
-1.667%
CYTX
2.17
+0.12
+5.85%
DXCM
92.23
+2.67
+2.98%
GNMK
10.65
+0.39
+3.80%
HALO
9.94
+0.17
+1.74%
ILMN
166.35
-0.07
-0.04%
INNV
0.54
-0.01
-1.80%
INO
9.88
+0.26
+2.70%
ISCO
1.99
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
134.88
-0.01
-0.01%
LPTN
1.95
-0.05
-2.50%
MBVX
0.6
-0.05
-7.69%
MEIP
1.36
0.00
-0.01%
MNOV
6.2
+0.13
+2.14%
MRTX
4.64
+0.08
+1.75%
MSTX
0.357
-0.006
-1.6249%
NBIX
50.23
+0.08
+0.16%
NUVA
62.2
+0.18
+0.29%
ONCS
1.82
+0.03
+1.68%
ONVO
4.28
-0.01
-0.23%
OREX
3.35
-0.03
-0.89%
OTIC
14.36
-0.1
-0.69%
QDEL
22.8
-0.44
-1.89%
RCPT
231.96
0.00
0.00%
RGLS
3.57
0.00
+0.14%
RMD
68.88
+3.18
+4.84%
SPHS
5.86
+0.46
+8.52%
SRNE
6.29
+0.1
+1.62%
TROV
5.63
+0.18
+3.30%
VICL
4.15
-0.05
-1.19%
VOLC
18
0.00
0.00%
ZGNX
9.13
+0.05
+0.55%
Home » Archive by Category

Xconomy

West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More

February 5, 2016 – 12:27 pm

The biggest news on the West Coast this week came from Stanford University. The school has lured decorated neuroscientist Marc Tessier-Lavigne away from New York’s Rockefeller University to be…

[[Click headline to continue reading.]]

Improving Odds for Women in Tech? Take Notes from Biotech

February 4, 2016 – 6:59 am

At our entrepreneurial support organization, the Council for Entrepreneurial Development (CED), we often joke about adhering to the proper dress and catering code for our networking events: jeans and…

[[Click headline to continue reading.]]

Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions

February 4, 2016 – 4:30 am

[Corrected, 2/4/16, 2:05pm. See below.] Three weeks ago the world’s biggest genomic sequencing company, Illumina (NASDAQ: ILMN), unveiled a spinout called Grail to make blood tests that could…

[[Click headline to continue reading.]]

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics

February 3, 2016 – 10:00 pm

[Corrected 2/8/16, 11:20 am. See below.] In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing…

[[Click headline to continue reading.]]

GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer

February 3, 2016 – 12:57 pm

Like many small biotechs, San Antonio, TX-based GenSpera has plenty of options for developing its cancer drug and limited resources to do so. While GenSpera’s treatment, called mipsagargin or G-202,…

[[Click headline to continue reading.]]

Ex-Tech CEO Steps Out of Retirement to Reinvent Medical Walker

February 3, 2016 – 5:00 am

Dave Purcell meant to stay retired after he ended his 23-year stint with Encad, a San Diego company he co-founded to manufacture large-format inkjet printers capable of printing poster-size images…

[[Click headline to continue reading.]]

Time to Ease On Down the Road

February 3, 2016 – 1:00 am

It’s been a real pleasure writing my guest op-ed pieces for Xconomy for the past six years. I’ve enjoyed sharing my thoughts about a wide spectrum of biopharma topics, and appreciated the feedback I…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More

January 29, 2016 – 12:55 am

The only major Republican presidential candidate who didn’t show up for last night’s debate was front-runner Donald Trump. He also made national news this week by announcing his intent to…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: StemCells, Five Prime, Qualcomm & More

January 22, 2016 – 1:30 pm

Bad weather has brought parts of the South and the Eastern seaboard to a halt today, but out west, we’re wearing our gumboots and splashing onward. While the rain drums steadily down, the news…

[[Click headline to continue reading.]]

BioTheranostics, Acquired in 2008, To Go Independent in $32M Deal

January 21, 2016 – 10:01 pm

San Diego-based bioTheranostics, which has operated since 2008 as a division of the French diagnostics conglomerate bioMérieux, said it has secured $32 million in financing to commercialize its…

[[Click headline to continue reading.]]